Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
Recently, there has been a positive trend to reduce mortality from myocardial infarction. One of the reasons for such dynamics is the development of angiographic service in our country and the increase in the number of primary percutaneous coronary interventions. One of the most serious complication...
Saved in:
| Main Authors: | A. S. Tereshchenko, Е. V. Merkulov, A. M. Samko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2085 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01) -
COMPUTER FORECASTING AND EXPERIMENTAL VALIDATION OF ANTIAGGREGATE PROPERTIES OF CETRINE, GLURENORM, MOEX AND DILTHIAZEM
by: Nikolay P. Votintsev
Published: (2011-03-01) -
Clinical case of using manual thrombus aspiration during percutaneous coronary intervention in a patient with ST-segment elevation myocardial infarction type 2
by: V. M. Mironov, et al.
Published: (2016-02-01) -
Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction
by: Mohamed Hassan Nab, et al.
Published: (2019-03-01) -
The no-reflow phenomenon: current treatment and prevention strategies
by: S. V. Dil, et al.
Published: (2025-04-01)